Case report. A myasthenic patient (Osserman II B), who received 0.1 mg.kg-1 cisatracurium during a propofol-fentanyl-O2:air anaesthesia, was monitored by Datex electromyography. The cisatracurium resulted in rapid onset of complete (100%) neuromuscular block in 3.6 min; a clinical duration (time from injection of cisatracurium to 25 % ratio of the first twitch of the train-of-four to the control twitch (T1/C ratio)) of 42 min; a recovery index (25% to 75 % T1/C ratio) of 37 min, and recovery TOF-ratios (ratio of the fourth to the first evoked response) of 0.75, 0.90, 0.95 and 1 in 65.5 min, 75.3 min, 84 min and 96.3 min respectively. Conclusion. The myasthenic patient is sensitive to cisatracurium, as evidenced by a more rapid onset and mor...
Background and objective: : Different drugs, including hypnotics, may influence the pharmacodynamic e...
Background: Cisatracurium in clinical practice is devoid of histamine-induced cardiovascular effects...
Introduction: The use of paralytics during rapid sequence intubation (RSI) in patients with myasthen...
Background: Neuromuscular-blocking drugs block neuromuscular transmission, causing paralysis of the ...
Different drugs, including hypnotics, may influence the pharmacodynamic effects of neuromuscular blo...
SummaryBackground and objectivesMyasthenia gravis (MG) is an autoimmune neurologic disease that affe...
Background and Aims: Neuromuscular blockers have become essential part of anaesthesiologist armament...
Background: Inhalational anesthetics potentiate nondepolarizing muscle relaxants. Cisatracurium is a...
Background and objective: Different drugs, including hypnotics, may influence the pharmacodynamic ef...
Cisatracurium ist ein nichtdepolarisierendes Muskelrelaxans (NMDR) und hat im Vergleich zu den ander...
Background and aims: Neuromuscular blockers have become essential part of anaesthesiologist armament...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
Study objective To demonstrate the effect of administering a precurarizing dose of cisatracurium or ...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
Background and objective: : Different drugs, including hypnotics, may influence the pharmacodynamic e...
Background: Cisatracurium in clinical practice is devoid of histamine-induced cardiovascular effects...
Introduction: The use of paralytics during rapid sequence intubation (RSI) in patients with myasthen...
Background: Neuromuscular-blocking drugs block neuromuscular transmission, causing paralysis of the ...
Different drugs, including hypnotics, may influence the pharmacodynamic effects of neuromuscular blo...
SummaryBackground and objectivesMyasthenia gravis (MG) is an autoimmune neurologic disease that affe...
Background and Aims: Neuromuscular blockers have become essential part of anaesthesiologist armament...
Background: Inhalational anesthetics potentiate nondepolarizing muscle relaxants. Cisatracurium is a...
Background and objective: Different drugs, including hypnotics, may influence the pharmacodynamic ef...
Cisatracurium ist ein nichtdepolarisierendes Muskelrelaxans (NMDR) und hat im Vergleich zu den ander...
Background and aims: Neuromuscular blockers have become essential part of anaesthesiologist armament...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
Study objective To demonstrate the effect of administering a precurarizing dose of cisatracurium or ...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
Background and objective: : Different drugs, including hypnotics, may influence the pharmacodynamic e...
Background: Cisatracurium in clinical practice is devoid of histamine-induced cardiovascular effects...
Introduction: The use of paralytics during rapid sequence intubation (RSI) in patients with myasthen...